A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes

The purpose of this study is to determine the efficacy of tirzepatide in participants with type 2 diabetes.

Trial Summary

Age Range
18 - 75 years
Conditions the trial is for
Type 2 Diabetes
What the trial is testing?
Tirzepatide
Could I receive a Placebo?
Yes
Enrollment Goal
111
Trial Dates
Oct 19, 2017 - Apr 24, 2018
How long will I be in the trial?
Your participation could last approximately 12 weeks and include 9 visits to the study center.
Trial Phase
II

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.